The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models
Open accessAbstract
Gene expression data from microarrays are being applied to predict preclinical and clinical endpoints, but the reliability of these predictions has not been established. In the MAQC-II project, 36 independent teams analyzed six microarray data sets to generate predictive models for classifying a sample with respect to one of 13 endpoints indicative of lung or liver toxicity in rodents, or of breast cancer, multiple myeloma or neuroblastoma in humans. In total, >30,000 models were built using many combinations of analytical methods. The teams generated predictive models without knowing the biological meaning of some of the endpoints and, to mimic clinical reality, tested the models on data that had not been used for training. We found that model performance depended largely on the endpoint and team proficiency and that different approaches generated models of similar performance. The conclusions and recommendations from MAQC-II should be useful for regulatory agencies, study committees and independent investigators that evaluate methods for global gene expression analysis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Using the common intra-site DEGs to validate the called inter-site DEGs, the MCC41, 42 showed that PEER also yields a higher accuracy than the original limmavoom method (Supplementary Fig. 22d,e), indicating that global data normalization analysis methods such as PEER can also be used to improve RNA-seq data across both Illumina and the PGM platforms.”
From Detecting and correcting systematic variation in large-scale RNA sequencing data (2014) · cites this paper as [42]
In the citing paper
“for instance, the Food and Drug Administration (FDA) agency of the USA employed the MCC as the main evaluation measure in the MicroArray II / Sequencing Quality Control (MAQC/SEQC) projects [41, 42].”
From The advantages of the Matthews correlation coefficient (MCC) over F1 score and accuracy in binary classification evaluation (2020) · cites this paper as [41]
In the citing paper
“Within the MicroArray Quality Control (MAQC)-II study [7], we observed, however, that the performance of gene expression models in predicting clinical outcome was limited and largely dependent on the respective clinical endpoint.”
From Comparison of RNA-seq and microarray-based models for clinical endpoint prediction (2015) · cites this paper as [7]
In the citing paper
“Within the MicroArray Quality Control (MAQC)-II study [7], we observed, however, that the performance of gene expression models in predicting clinical outcome was limited and largely dependent on the respective clinical endpoint.”
From Comparison of RNA-seq and microarray-based models for clinical endpoint prediction (2015) · cites this paper as [7]
In the citing paper
“Considering the fact that the nature of the clinical endpoint strongly affects a classifier’s performance [7, 18], we included endpoints that are known to cover a broad range of predictive difficulties (low difficulty, SEX, and CLASS LABEL; intermediate difficulty, EFS ALL, and OS ALL; high difficulty, EFS HR, and OS HR).”
From Comparison of RNA-seq and microarray-based models for clinical endpoint prediction (2015) · cites this paper as [7]
In the citing paper
“Evaluation of the prediction performances in the validation set revealed that the endpoint represents the most relevant factor affecting model performances, which is well in line with the findings of the MAQC-II study [7].”
From Comparison of RNA-seq and microarray-based models for clinical endpoint prediction (2015) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Unbiased Recursive Partitioning: A Conditional Inference Framework
Hothorn, T., Hornik, K., & Zeileis, A. (2006) · Journal of Computational and Graphical Statistics · doi:10.1198/106186006x133933 · Cited by 4,021
Comparison of Discrimination Methods for the Classification of Tumors Using Gene Expression Data
Dudoit, S., Fridlyand, J., & Speed, T. P. (2002) · Journal of the American Statistical Association · doi:10.1198/016214502753479248 · Cited by 2,671 · cited 1×
“Although previous studies have compared and benchmarked individual steps in the model development proces”
ResultMAQC Consortium, Shi, L., Shi, L., Reid, L. H., Jones, W. D., Shippy, R., Warrington, J. A., Baker, S. C., Collins, P. J., de Longueville, F., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1239 · Cited by 2,126
Self-citationThat BLUP is a Good Thing: The Estimation of Random Effects
Robinson, G. K. (1991) · Statistical Science · doi:10.1214/ss/1177011926 · Cited by 1,694
Selection bias in gene extraction on the basis of microarray gene-expression data
Ambroise, C., & McLachlan, G. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102102699 · Cited by 1,537 · cited 1×
“, poor data quality and/or insufficient cross-validation of all model development step”
BackgroundDavé, S. S., Wright, G. W., Tan, B. K., Rosenwald, A., Gascoyne, R. D., Chan, W. C., Fisher, R. I., Braziel, R. M., Rimsza, L. M., Grogan, T. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041869 · Cited by 1,417 · cited 1×
“Previously, reanalysis of a widely cited single stud”
BackgroundMicroarray data analysis: from disarray to consolidation and consensus
Allison, D. B., Cui, X., Page, G. P., & Sabripour, M. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1749 · Cited by 1,339
Buyse, M. E., Loi, S., Veer, L. V., Viale, G., Delorenzi, M., Glas, A. M., Saghatchian, M., Bergh, J. C. S., Lidereau, R., Ellis, P., et al. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj329 · Cited by 1,238
Shedden, K., Taylor, J. M. G., Misek, D. E., Chang, A. C., Hanash, S., Kuick, R. D., Beer, D. G., Enkemann, S. A., Yeatman, T. J., Eschrich, S. A., et al. (2008) · Nature Medicine · doi:10.1038/nm.1790 · Cited by 1,176
Flagged first, then by citations
Cited by
Sorted by citations
Items 801–894 of 894
Chen, J. J. (2011) · Pharmacogenomics · doi:10.2217/pgs.11.26
Tang, J., & Wang, F. (2015) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2015.12.095
’Omics in Organ Toxicity, Integrative Analysis Approaches, and Knowledge Generation
Suter‐Dick, L. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397862-2.00012-7
Pathway Analysis and Its Applications
Mathur, R., & Motsinger‐Reif, A. A. (2015) · Advances in bioinformatics and biomedical engineering book series · doi:10.4018/978-1-4666-6611-5.ch010
ToxicogenomicsIn vitro: Gene Expression Signatures for Differentiating Genotoxic Mechanisms
Buick, J. K., & Yauk, C. L. (2016) · Royal Society of Chemistry eBooks · doi:10.1039/9781782624059-00076
Application of In Vivo Genomics to the Prediction of Chemical-Induced (hepato)Carcinogenesis
Auerbach, S. S., & Paules, R. S. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397862-2.00002-4
Toxicogenomics in Drug Discovery Toxicology
Jeffy, B. D., Milano, J., & Brennan, R. (2016) · doi:10.1002/9781119053248.ch45
Computational Modeling for Differential Analysis of RNA-seq and Methylation data
Wang, X. (2016) · VTechWorks (Virginia Tech)
O’Neill, R. T. (2013) · Lecture notes in statistics · doi:10.1007/978-1-4614-8981-8_17
Biomarkers of tolerance: searching for the hidden
Rebollo‐Mesa, I., Sagoo, P., & Hernández-Fuentes, M. P. (2011)
Erratum to: Frontiers in Wastewater Treatment and Modelling
Mannina, G. (2017) · Lecture notes in civil engineering · doi:10.1007/978-3-319-58421-8_116
OBSOLETE: Transcriptome and Epigenome Applications for Coronary Heart Disease Research
Joehanes, R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.99574-6
Wolff, A. (2018) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7165
Developing statistical and bioinformatic analysis of genomic data from tumours
Thakur, R. (2018) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
A deep learning approach to the structural analysis of proteinsPreprint
Giulini, M., & Potestio, R. (2019) · arXiv (Cornell University) · doi:10.48550/arxiv.1901.00915
Informatics Methods for Molecular Profiling
Aliferis, C., Ma, S., & Winterhoff, B. J. N. (2019) · Health informatics · doi:10.1007/978-3-030-18626-5_8
Hierarchical Structural Component Models for Integrative Analysis of miRNA and mRNA expression data
김용강 (2018) · Seoul National University Open Repository (Seoul National University)
Bayesian Multilevel-multiclass Graphical Model
Lin, J. (2019) · VTechWorks (Virginia Tech)
Analytical Challenges of Next-generation Sequencing in Precision Medicine
Liebers, M. R. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781788019958-00153
Wang, Y., Wang, M., Sun, X., Yao, L., Wang, M., Dong, H., Li, X., He, M., & Xu, Y. (2021) · Research Square · doi:10.21203/rs.3.rs-148991/v1
Liu, D., Xu, T., Zhou, H., Yang, Q., Mo, X., Shi, D., Ai, J., Zhang, J., Tao, Y., Donghua, W., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-208796/v1
Identification of Pathogenesis and Prognoses of Relapse in Myeloma by Bioinformatic MethodPreprint
Zhong, H., Liu, Y., Duan, J., Chen, X., Xiong, H., Liao, K., & Huang, C. (2021) · Research Square · doi:10.21203/rs.3.rs-1100874/v1
43 弱毒日本脳炎ウイルス(ML-17株)の研究(微生物学分科会)(第72回日本獣医学会記事)
吉田, 巌., 猪熊, 悦., 高木, 光., 石原, 美., 合田, 英., 高延, 壮., 山下, 高., 高久, 慶., & 国田, 信. (1971)
Genomic Applications in Breast Carcinoma
Mattos‐Arruda, L. D., Weigelt, B., & Reis-Filho, J. S. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0727-4_23
Wang, Y., Wang, M., Sun, X., Yao, L., Wang, M., Dong, H., Li, X., He, M., & Xu, Y. (2021) · Research Square · doi:10.21203/rs.3.rs-154352/v1
Data Mining and Meta-Analysis on DNA Microarray Data
Paparountas, T., Nikolaidou-Katsaridou, M. N., Rustici, G., & Aidinis, V. (2013) · IGI Global eBooks · doi:10.4018/978-1-4666-3604-0.ch062
Shi, L. M., Shang, J., Zhao, Y., Jiang, H., Yang, J., Zhang, N., Ren, L., Chen, Q., Yu, Y., Chen, H., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1218087/v1
Transcriptome and Epigenome Applications for Coronary Heart Disease Research
Joehanes, R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809657-4.99574-7
Taroncher‐Oldenburg, G., Cain, C., & Lou, K.-J. (2014) · Science-Business eXchange · doi:10.1038/scibx.2014.1061
(2013) · Elsevier eBooks · doi:10.1016/b978-0-12-410407-5.16001-5
(2014) · Nature Biotechnology · doi:10.1038/nbt.3021
Appendix A: Drug Metabolism in Drug Discovery
Coleman, M. D. (2020) · Wiley eBooks · doi:10.1002/9781119658016.app1
Harbron, C. G. (2016) · Statistics for biology and health · doi:10.1007/978-3-319-23558-5_14
Verma, N., Müller, A., Kothari, C., Panayotopoulou, E. G., Kedan, A., Selitrennik, M., Mills, G. B., Nguyen, L. K., Shin, S., Karn, T., et al. (2023) · doi:10.1158/0008-5472.22412934
Verma, N., Müller, A., Kothari, C., Panayotopoulou, E. G., Kedan, A., Selitrennik, M., Mills, G. B., Nguyen, L. K., Shin, S., Karn, T., et al. (2023) · doi:10.1158/0008-5472.22412934.v1
Maneix, L., Iakova, P. A., Moree, S. E., Hsu, J. I., Mistry, R. M., Stossi, F., Lulla, P., Sun, Z., Sahin, E., Yellapragada, S. V., et al. (2023) · doi:10.1158/2767-9764.22546592
Maneix, L., Iakova, P. A., Moree, S. E., Hsu, J. I., Mistry, R. M., Stossi, F., Lulla, P., Sun, Z., Sahin, E., Yellapragada, S. V., et al. (2023) · doi:10.1158/2767-9764.22546592.v1
A study of toxicogenomics and its current applications in the safety of traditional Chinese medicine
Lian, X., Ai, N., Lu, X., & Fan, X. (2020) · Journal of Holistic Integrative Pharmacy · doi:10.1016/s2707-3688(23)00028-6
Principles of Rigorous Development and of Appraisal of ML and AI Methods and Systems
Aliferis, C., & Simon, G. (2024) · Health informatics · doi:10.1007/978-3-031-39355-6_5
Tian, S., Zhan, D., Yu, Y., Wang, Y., Liu, M., Tan, S., Li, Y., Song, L., Qin, Z., Li, X., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24098169
Tian, S., Zhan, D., Yu, Y., Wang, Y., Liu, M., Tan, S., Li, Y., Song, L., Qin, Z., Li, X., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24098163
Tian, S., Zhan, D., Yu, Y., Wang, Y., Liu, M., Tan, S., Li, Y., Song, L., Qin, Z., Li, X., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24098157
Tian, S., Zhan, D., Yu, Y., Wang, Y., Liu, M., Tan, S., Li, Y., Song, L., Qin, Z., Li, X., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24098151
Tian, S., Zhan, D., Yu, Y., Wang, Y., Liu, M., Tan, S., Li, Y., Song, L., Qin, Z., Li, X., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24098172
Tian, S., Zhan, D., Yu, Y., Wang, Y., Liu, M., Tan, S., Li, Y., Song, L., Qin, Z., Li, X., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24098160
Tian, S., Zhan, D., Yu, Y., Wang, Y., Liu, M., Tan, S., Li, Y., Song, L., Qin, Z., Li, X., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24098166
Environmental DNA and toxicogenomics in ecological health risk assessment
Yang, J., Xie, Y., Mu, Y., Li, F., & Zhang, X. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-14170-6.00022-6
GENETIC DETERMINANTS OF DRUG RESPONSE IN DIFFUSE LARGE B-CELL LYMPHOMA
Issa, I. I. (2024) · VBN Forskningsportal (Aalborg Universitet) · doi:10.54337/aau718060352
Pennello, G. A., Cooner, F., Irony, T., Bandeen‐Roche, K., Gomatam, S. V., Gwise, T. E., Kessler, L. G., Kotz, R. M., Louis, T. A., Meier, K., et al. (2024) · Statistics in Biopharmaceutical Research · doi:10.1080/19466315.2024.2395196
Understanding and predicting induced immunotoxicity from gene expression
Bhat, E. A., Ali, T., Sajjad, N., & Kumar, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18502-1.00003-1
Successful use of immunotoxicogenomics as a screening tool
Firdous, P., Nissar, K., Ahmad, M. B., & Ali, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18502-1.00008-0
AI and deep learning in cancer genomics
Awasthi, P., Singh, N. K., Gupta, A., Anand, N., & Hasan, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-27574-6.00017-5
Benefits and challenges of OMICS data integration at the pathway level
Borisov, N. M., & Sorokin, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15568-0.00010-8
Flores, R., Nihalani, R., Umur, S., Vigneault, F., & Novak, R. (2025) · Research Square · doi:10.21203/rs.3.rs-6130021/v1
Cordier, C., Jézéquel, P., Campone, M., Panloup, F., & Basseville, A. (2025) · Bioinformatics · doi:10.1093/bioinformatics/btaf310
Kuzudisli, C., Qaqish, B. F., Bakır-Güngör, B., & Yousef, M. (2025) · doi:10.1109/ubmk67458.2025.11206851
“Alternatively, selecting the probe with the highest variance across samples has been suggested as a means to retain the most dynamically informative signal, potentially enhancing class discrimination in predictive models [7].”
Nguyen, N. U. N., Tong, C., Fry, M., & Stamper, B. D. (2025) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2025.2583401
Takeshita, T., Iwase, H., Wu, R., Ishikawa, T., Yan, L., & Takabe, K. (2025) · iScience · doi:10.1016/j.isci.2025.114486
Additional file 1 of Impact of gene annotation choice on the quantification of RNA-seq data
Chisanga, D., Liao, Y., & Shi, W. (2022) · Figshare · doi:10.6084/m9.figshare.19470326
Tian, S., Zhan, D., Yu, Y., Wang, Y., Liu, M., Tan, S., Li, Y., Song, L., Qin, Z., Li, X., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24098148
Omar, M., Nuzzo, P. V., Ravera, F., Bleve, S., Fanelli, G. N., Zanettini, C., Valencia, I., & Marchionni, L. (2024) · Figshare · doi:10.6084/m9.figshare.26640136
Omar, M., Nuzzo, P. V., Ravera, F., Bleve, S., Fanelli, G. N., Zanettini, C., Valencia, I., & Marchionni, L. (2024) · Figshare · doi:10.6084/m9.figshare.26640139
Omar, M., Nuzzo, P. V., Ravera, F., Bleve, S., Fanelli, G. N., Zanettini, C., Valencia, I., & Marchionni, L. (2024) · Figshare · doi:10.6084/m9.figshare.26640142
Niu, J., Yang, J., Guo, Y., Qian, K., & Wang, Q. (2022) · Figshare · doi:10.6084/m9.figshare.20291118
Additional file 2 of LIQA: long-read isoform quantification and analysis
Hu, Y., Fang, L., Chen, X., Zhong, J. F., Li, M., & Wang, K. (2021) · Figshare · doi:10.6084/m9.figshare.14803829
Additional file 1 of LIQA: long-read isoform quantification and analysis
Hu, Y., Fang, L., Chen, X., Zhong, J. F., Li, M., & Wang, K. (2021) · Figshare · doi:10.6084/m9.figshare.14803826
Yu, Y., Zhang, N., Mai, Y., Ren, L., Chen, Q., Cao, Z., Chen, Q., Liu, Y., Hou, W., Yang, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24098262
Yu, Y., Zhang, N., Mai, Y., Ren, L., Chen, Q., Cao, Z., Chen, Q., Liu, Y., Hou, W., Yang, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24098256
Tian, S., Zhan, D., Yu, Y., Wang, Y., Liu, M., Tan, S., Li, Y., Song, L., Qin, Z., Li, X., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24098175
AI in the discovery and development of antibody therapeutics
Peckner, R., Visweswaraiah, J., & Higginson-Scott, N. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29808-0.00034-0
Opakunle, A., Shan, Y., Huang, Y., Printzis, C., Stanhope, C. T., Stranger, B. E., & Huang, R. S. (2026) · Human Genetics and Genomics Advances · doi:10.1016/j.xhgg.2026.100596
Molecular and physiological characterization of grapevine rootstock adaptation to drought
Peccoux, A. (2011) · theses.fr (ABES) · doi:10.70675/ab4b4e5dzb19ez45d7z9b84zb37423122088
Dernoncourt, D. (2014) · theses.fr (ABES) · doi:10.70675/b309e486z578dz49f2z8d0dz8e4873f8ef8a
Phan, B.-C., Ma, T.-T., Do, T., & Nguyen, H.-H. (2026) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2026.109057
The Role of Machine Learning in Pharmaceutical Biotechnology
Jangra, J., Kaur, R., & Kumar, R. (2025) · Springer handbooks · doi:10.1007/978-3-032-01636-2_32
BOTAN, R. D. N., & de Sousa, J. B. (2026) · Breast Cancer Research · doi:10.1186/s13058-026-02298-5
Gao, Z., Liu, J., Sun, Y., Bai, C., Yang, H., Xu, H., Hao2, L., Song, L., Suo, M., & Chen, J. (2026) · Genomics · doi:10.1016/j.ygeno.2026.111268
USADAE: a deep learning approach to disentangle hidden covariates in RNA-seq data
Chen, X., Guo, L., Chen, Y., Mo, D., & Liu, X. (2026) · Briefings in Bioinformatics · doi:10.1093/bib/bbag261
Liu, W., Yan, C., Wu, H., Wu, C., Cai, Z., Wang, Z., Zhuang, W.-H., Li, M., & Guo, J. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1880529
Gaikwad, A. S. (2026) · Current Pharmaceutical Analysis · doi:10.1016/j.cpan.2026.08.004
Oshi, M., Kurozumi, S., Hizume, M., Yamada, A., Shah, Z., Endo, I., & Takabe, K. (2026) · Modern Pathology · doi:10.1016/j.modpat.2026.101072
Integration of artificial intelligence and multi-omics for precision medicine
Marei, H. E. S., Cenciarelli, C., & Vagni, D. (2026) · Functional & Integrative Genomics · doi:10.1007/s10142-026-02024-6
Weng, X., Tang, Y., Wang, C., Huang, Z., Huang, X., & Wang, J. (2026) · PLoS ONE · doi:10.1371/journal.pone.0355652
“Pathological complete response (pCR) after neoadjuvant systemic therapy is associated with improved long-term outcomes in triple-negative breast cancer (TNBC), but a molecular correlate observed in one dataset is not automatically a clinically useful or broadly generalizable predictor [1,2].”
Kolev, M., Naskinova, I., Lazarova, M., Klisurov, V., & Kalinov, H. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27209273
“The main lesson of the second phase of the MicroArray Quality Control project (MAQC-II) was that reproducibility across platforms depends on this kind of procedural discipline [47].”
Model Selection in High-Dimensional Misspecified ModelsPreprint
Basu, P., Feng, Y., & Lv, J. (2014) · arXiv (Cornell University) · doi:10.48550/arxiv.1412.7468
Fong, I. L. (2012) · Unimas Institutional Repository (Universiti Malaysia Sarawak)
Microarray-Based Investigations in Cancer
Starmans, M. H. W., Haider, S. A., Yao, C. Q., Lambin, P., & Boutros, P. C. (2014) · Springer eBooks · doi:10.1007/978-1-4899-8050-2_7
Metadata
- Authors
- MAQC Consortium
- Venue
- Nature Biotechnology
- Published
- 2010-07-30
- Volume
- 28
- Issue
- 8
- Pages
- 827-838
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- PMC
- PMC3315840
- OpenAlex
- W2021560851
- Cited by
- 889
- References
- 63
- Citations by year
- 2026: 13 · 2025: 33 · 2024: 39 · 2023: 35 · 2022: 40 · 2021: 58 · 2020: 61 · 2019: 58 · 2018: 46 · 2017: 35 · 2016: 57 · 2015: 54 · 2014: 87 · 2013: 85 · 2012: 79
- FWCI
- 34.94
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Institute of Process Engineering, CAS Institutional Repository (submittedVersion, cc-by-nc-sa)
- IRIS (submittedVersion)
- Repository of Futwangen University of Applied Sciences (Furtwangen University) (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- National Institutes of Health (Z99 LM999999, Z99 HL999999, Z99 MH999999, Z99CL999999)
- National Cancer Institute (CA97513-01, CA55819-01A1, R00CA126184, P01CA055819, R33CA097513)
- National Institute of General Medical Sciences (T32GM074906, R01GM083084, R01GM083226, R01GM072611)
- National Center for Research Resources (R01RR021967)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Keywords
- microarray quality control, gene expression profiling, prediction model, genomic classifier, model validation, pulmonary toxicity, hepatotoxicity, breast cancer, multiple myeloma, neuroblastoma, rodent toxicity, method comparison, reproducibility
- MeSH terms
- Animals, Breast Neoplasms, Disease Models, Animal, Female, Humans, Liver Diseases, Lung Diseases, Multiple Myeloma, Neoplasms, Neuroblastoma, Predictive Value of Tests, Quality Control, Survival Analysis, Guidelines as Topic, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
